Viveon Health Acquisition Corp. (VHAQ)
USD 10.0
(0.0%)
USD 10.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.75 Million | -2.08 Million | 642.3 Thousand | - | - | - |
| Net Income | -486.78 Thousand | 2.48 Million | -2.23 Million | -9.22 Million | -8.13 Million | -9.52 Million |
| Depreciation & Amortization | 3.64 Million | - | - | 865 Thousand | 1.05 Million | 1.92 Million |
| Deferred income taxes | -39.25 Thousand | - | - | 474 Million | -93 Million | 309 Million |
| Stock-based compensation | -8.51 Million | 157.14 Thousand | 1018.66 | 87 Million | 84 Million | 341 Million |
| Change in working capital | 717.59 Thousand | 1.86 Million | 668.28 Thousand | -481 Thousand | 129 Thousand | -44 Thousand |
| Other non-cash items | 2.92 Million | -6.59 Million | 2.21 Million | 2.2 Million | 2.04 Million | 4.22 Million |
| Investing Cash Flow | 150.19 Million | - | -203.26 Million | 12.27 Million | -189 Thousand | -152 Thousand |
| Investments in PPE | - | - | - | -2.06 Million | -189 Thousand | -152 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -2.26 Million | - | -203.26 Million | - | - | - |
| Sales/Maturities of investments | 152.45 Million | - | - | - | - | - |
| Other Investing Activities | 150.19 Million | - | -487.83 Thousand | 14.33 Million | - | - |
| Financing Cash Flow | -148.81 Million | -619.38 Thousand | 205.71 Million | 3.9 Million | 9.68 Million | 200 Thousand |
| Debt repayment | -4.07 Million | -228.75 Thousand | -228.75 Thousand | -1.33 Million | - | - |
| Dividends payments | - | - | - | -252.54 Thousand | - | - |
| Common Stock Repurchased | -152.45 Million | - | - | 3.47 Million | - | - |
| Common Stock Issuance | -437 Thousand | -25.74 Thousand | 205.48 Million | 3.9 Million | 9.68 Million | 200 Thousand |
| Other Financing Activities | 8.87 Million | -390.62 Thousand | 493.72 Thousand | -2.57 Million | - | 200 Million |
| Accounts receivables | 15 Thousand | -15 Thousand | - | -343 Thousand | 151 Thousand | -143 Thousand |
| Accounts payables | 179.07 Thousand | 47.72 Thousand | 958.29 Thousand | -41 Million | 12 Million | -132 Million |
| Inventory | 702.59 Thousand | 15 Thousand | - | -90 Thousand | -70 Thousand | -34 Thousand |
| Other working capital | -179.07 Thousand | 1.81 Million | 668.28 Thousand | -48 Thousand | 48 Thousand | 133 Thousand |
| Cash at beginning of period | 395.23 Thousand | 3.09 Million | - | 5.61 Million | 3.05 Million | 10.45 Million |
| Cash at end of period | 19.84 Thousand | 395.23 Thousand | 3.09 Million | 713 Thousand | 5.61 Million | 3.05 Million |
| Capital Expenditure | - | - | - | -2.06 Million | -189 Thousand | -152 Thousand |
| Effect of forex changes on cash | - | - | - | -3.8 Million | - | - |
| Net cash flow / Change in cash | -375.38 Thousand | -2.7 Million | 3.09 Million | -4.9 Million | 2.56 Million | -7.39 Million |
| Free Cash Flow | -1.75 Million | -2.08 Million | 642.3 Thousand | -10.86 Million | -7.12 Million | -7.59 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | 262.93 | 2.94 Million | -14.46 Million | -2.38 Million |
| Depreciation & Amortization | - | - | 8795.00 | 2.54 Million | 1.97 Million | 737.93 Thousand |
| Deferred income taxes | - | - | -99.5 Thousand | -39.25 Thousand | - | - |
| Stock-based compensation | - | - | - | - | 847.05 Thousand | - |
| Change in working capital | - | - | 425.02 | -454.33 Thousand | 8.2 Million | 483 Thousand |
| Other non-cash items | - | - | -861.94 | -2.72 Million | -86.54 Thousand | 707.77 Thousand |
| Investing Cash Flow | - | - | 33.7 Thousand | -580 Thousand | 1.05 Million | -720 Thousand |
| Investments in PPE | - | - | - | - | -28.75 Thousand | - |
| Acquisitions | - | - | - | - | 100 Thousand | - |
| Investment purchases | - | - | - | -580 Thousand | - | -720 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 33.7 Thousand | -580 Thousand | 980 Thousand | -720 Thousand |
| Financing Cash Flow | - | - | -33.47 Thousand | 587 Thousand | 2.15 Million | - |
| Debt repayment | - | - | - | -655 Thousand | -5.58 Million | - |
| Dividends payments | - | - | -225.93 Thousand | - | - | - |
| Common Stock Repurchased | - | - | -34 Thousand | - | - | - |
| Common Stock Issuance | - | - | - | -68 Thousand | - | - |
| Other Financing Activities | - | - | 532.00 | 1.31 Million | 7.74 Million | 230.04 Thousand |
| Accounts receivables | - | - | - | - | 3056.00 | - |
| Accounts payables | - | - | -3228.00 | 17.47 Thousand | 1.08 Million | 48.75 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 425.02 | -471.81 Thousand | 7.11 Million | 434.25 Thousand |
| Cash at beginning of period | - | - | 19.85 | 286.09 Thousand | 975.07 Thousand | 1.46 Million |
| Cash at end of period | - | - | 77.86 | 19.84 Thousand | 205.63 Thousand | 286.09 Thousand |
| Capital Expenditure | - | - | - | - | -28.75 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 58.01 | -266.24 Thousand | -769.43 Thousand | -1.17 Million |
| Free Cash Flow | - | - | -173.99 | -273.24 Thousand | -4 Million | -456.17 Thousand |
9928
PTG
ADMQ
KOZAL
SIPTL
2805